Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00438776 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling
A Phase 3 study, sponsored by Lindner Center of HOPE.
- Completed
- Registry status
- Phase 3
- Development phase
- 42
- Enrollment target
NCT00438776 is a Phase 3 study that has completed, run by Lindner Center of HOPE. The registered enrollment target is 42 participants.
The verdict
NCT00438776, a Phase 3 study, has completed, sponsored by Lindner Center of HOPE.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate the efficacy (effectiveness) and safety of olanzapine in treating pathological gambling.
Interventions
- DRUG olanzapine
- DRUG sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00438776
The ClinicalTrials.gov registry entry for NCT00438776 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lindner Center of HOPE, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which olanzapine is the first listed.
NCT00438776 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00438776 about?
NCT00438776 is a clinical study titled "Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling". The purpose of this research study is to evaluate the efficacy (effectiveness) and safety of olanzapine in treating pathological gambling.
What is the current status of trial NCT00438776?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 42 participants. The study started on 2007-02. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00438776?
The interventions under investigation include: olanzapine (DRUG), sugar pill (DRUG).
Who is sponsoring clinical trial NCT00438776?
This trial is sponsored by Lindner Center of HOPE, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.